Tokio Marine Asset Management CO LTD Clovis Oncology, Inc. Transaction History

Tokio Marine Asset Management CO LTD

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2017 Jan 11, 2018	BUY	N/A	11,988	11,988 $760,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.